Skip to main content

M E 33 Pill - white round

Pill with imprint M E 33 is White, Round and has been identified as Erlotinib Hydrochloride 150 mg. It is supplied by Mylan Pharmaceuticals Inc.

Erlotinib is used in the treatment of Non-Small Cell Lung Cancer; Pancreatic Cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M E 33

Erlotinib hydrochloride 150 mg M E 33

Erlotinib Hydrochloride

M E 33
150 mg
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-7133 (Discontinued)

Get help with Imprint Code FAQs.

Related images for "M E 33"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.